Sign inJoin waitlistJoin the waitlist

MM

Michelle Mierzwa

Physician · University of Michigan Health - Sparrow

Credentials: · · · ·

History

University of Michigan Health - Sparrow
2026–Present

Radiation Oncology
University of Cincinnati Medical Center Inc.
2004–2008
Christ Hospital
2003–2004
University of Cincinnati College of Medicine
1999–2003

Research

Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma
Clinical Cancer Research · 2022 · 178 citations
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement
International journal of radiation oncology · 2020 · 149 citations
Radiation resistance in head and neck squamous cell carcinoma: dire need for an appropriate sensitizer
Review · Oncogene · 2020 · 142 citations

Keith Casper
48 papers
MS
Matthew Spector
39 papers
PS
Paul Swiecicki
38 papers
Mark Prince
35 papers
FW
Francis Worden
34 papers
Andrew Shuman
32 papers
SC
Steven Chinn
32 papers
Kelly Malloy
30 papers
Jennifer Shah
28 papers
Chaz Stucken
27 papers
AE
Avraham Eisbruch
26 papers
GW
Gregory Wolf
19 papers

Clinical trials

Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer
Principal investigator · Active not recruiting · Phase 2
University of Michigan Rogel Cancer Center
2023–2028
A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)
Principal investigator · Recruiting · Phase 2
University of Michigan Rogel Cancer Center
2023–2030
Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer
Principal investigator · Completed · Phase 2
University of Michigan Rogel Cancer Center
2019–2024
Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer
Principal investigator · Completed · Phase 2
University of Michigan Rogel Cancer Center
2018–2025